Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06980597 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

StatusRecruiting
PhasePhase 1
Started2025-06
View on ClinicalTrials.gov ↗
This study aims to characterize the safety, tolerability, pharmacokinetics, and preliminary efficacy of OL-108 in relapsed/refractory autoimmune diseases.
Trial Details
NCT Number NCT06980597
Lead Sponsor Beijing GoBroad Hospital
Conditions Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM), Systemic Sclerosis (SSc), ANCA Associated Vasculitis (AAV)
Enrollment 44 participants
Start Date 2025-06
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-20